Monte Rosa Therapeutics Cash Flow Statement (2020-2026) | GLUE

Cash Flow Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-102.05M-93.43M-64.82M-26.47M-27.32M-30.78M-32.04M-35.18M-34.88M-33.25M-31.98M-30.31M-23.86M30.73M46.88M-12.29M-27.08M-29.49M-44.55M-43.40M
Depreciation and Depletion (Quarter)
0.60M0.83M0.75M0.89M1.03M1.02M1.20M1.39M1.83M1.85M1.90M2.06M2.10M2.06M2.05M2.12M2.10M2.09M2.03M1.91M
Share-based Compensation (Quarter)
26.10M1.86M2.25M35.50M0.20M3.33M3.97M0.10M33.10M4.07M4.87M4.50M4.28M4.47M5.30M4.89M4.36M4.31M49.40M5.97M
Cash from Operations (Quarter)
-17.79M-14.17M-27.40M-20.50M-20.60M-23.96M-23.41M-25.32M-24.71M29.63M-38.16M-27.77M-20.99M128.92M-45.49M-34.72M100.43M-43.01M-37.37M-44.11M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)
0.60M0.83M0.75M0.89M1.03M1.02M1.20M1.39M1.83M1.85M1.90M2.06M2.10M2.06M2.05M2.12M2.10M2.09M2.03M1.91M
Change in Working Capital
Change in Account Payables (Quarter)
-4.25M4.74M-2.18M-0.36M1.65M0.15M0.31M-1.00M0.69M5.77M-5.07M0.39M-2.38M13.31M-10.87M-1.10M8.88M-10.61M4.38M-1.49M
Change in Accured Expenses (Quarter)
5.88M-0.14M-3.56M1.36M1.16M2.07M-3.29M2.77M2.79M1.29M-3.89M2.04M2.33M3.70M-2.61M-2.47M4.19M8.73M-3.71M2.21M
Other Working Capital Changes (Quarter)
2.26M-0.89M0.61M0.08M1.43M0.01M-0.55M0.23M50.31M2.29M0.95M-9.22M89.35M0.00M-106.91M110.22M-3.91M2.92M-8.97M
Investing Activities
Capital Expenditures (Quarter)
1.79M-1.25M0.79M0.14M3.81M8.16M9.18M6.51M-14.42M17.77M0.98M2.42M0.40M-3.75M0.30M2.98M-2.84M-0.29M2.74M3.85M
Sales of Property, Plant and Equipment (Quarter)
0.01M0.12M-0.02M0.06M
Change in Acquisitions & Divestments (Quarter)
130.30M-130.30M45.63M31.07M-31.07M119.67M67.31M14.82M70.52M37.25M39.37M46.05M104.76M89.36M72.87M51.94M
Cash from Investing Activities (Quarter)
-1.69M-3.05M-180.52M-14.25M29.49M-53.94M20.33M18.55M35.63M14.30M9.85M-61.16M37.75M-30.90M-100.23M25.32M38.14M-65.07M-261.00M-28.86M
Financing Activities
Other financing activities (Quarter)
-0.13M0.15M0.10M-0.25M0.44M0.02M0.28M1.71M0.01M0.25M49.75M-49.32M0.38M0.01M-0.01M0.36M5.36M4.52M2.60M
Cash from Financing Activities (Quarter)
29.46M-0.14M0.15M0.10M-0.22M20.43M0.02M1.20M1.10M25.17M0.25M98.02M0.01M0.61M0.01M0.36M0.35M29.62M328.33M3.21M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
-143.00M13.51M6.55M24.25M
Additional items
Change in Cash (Quarter)
9.97M-17.35M-207.77M-34.65M8.67M-57.47M-3.06M-5.57M12.02M69.10M-28.07M9.10M16.77M98.63M-145.71M-9.03M138.91M-78.46M29.97M-69.76M
Free Cash Flow (Quarter)
-19.58M-12.92M-28.20M-20.65M-24.41M-32.12M-32.59M-31.84M-10.28M11.86M-39.15M-30.19M-21.39M132.68M-45.80M-37.70M103.27M-42.72M-40.10M-47.97M
Net Cash Flow (Quarter)
9.97M-17.35M-207.77M-34.65M8.67M-57.47M-3.06M-5.57M12.02M69.10M-28.07M9.10M16.77M98.63M-145.71M-9.03M138.91M-78.46M29.97M-69.76M